What is Dianthus Therapeutics's debt-to-assets?

Dianthus Therapeutics (DNTH) reported debt-to-assets of 0× in Q1 2026.

How has Dianthus Therapeutics's debt-to-assets changed year-over-year?

Dianthus Therapeutics's debt-to-assets decreased by 72.5% year-over-year, from 0× to 0×.

What is the long-term trend for Dianthus Therapeutics's debt-to-assets?

Over 3 years (2022 to 2025), Dianthus Therapeutics's debt-to-assets has grown at a -80.7% compound annual growth rate (CAGR), from 0.4× to 0×.

What does debt-to-assets mean?

Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.

Dianthus Therapeutics DNTH Debt-to-assets

Debt-to-assets at other companies

Johnson & JohnsonJNJ

0.3×0.0×

AmgenAMGN

0.6×0.0×

Spyre Therapeutics, Inc.SYRE

0×0.0×

Kymera TherapeuticsKYMR

0×0.0×

Protagonist TherapeuticsPTGX

0×0.0×

TG TherapeuticsTGTX

0.5×+0.1×

Other financials

Income statement

See full

Revenue$396.0K-81.8%

Operating income-$46.5M-40.3%

Net income-$40.8M-38.4%

EPS (diluted)-$0.85-3.7%

Balance sheet

See full

Cash & equivalents$627.7M+6,105%

Total debt$1.4M-2.3%

Total equity$1.2B+266%

Total assets$1.2B+258%

Cash flow

See full

Operating cash flow-$28.9M-4.4%

CapEx$10.0K-58.3%

Free cash flow-$28.9M-4.4%

Valuation

See full

Market cap$4.51B+662%

Profitability

See full

Operating margin-4,558.4%-9,354pp

Net margin-4,104.8%-7,304pp

FCF margin-3,561.6%-6,956pp

Returns & leverage

See full

Return on equity-28.6%+3.2pp

Debt / equity0×0.0×

Current ratio29.3×+13.3×

Where this comes from

Calculated from Dianthus Therapeutics’s reported figures.

total debt/total assets=0×

Based on the most recent quarter.

The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dianthus Therapeutics's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dianthus Therapeutics's debt-to-assets?: Dianthus Therapeutics (DNTH) reported debt-to-assets of 0× in Q1 2026.
How has Dianthus Therapeutics's debt-to-assets changed year-over-year?: Dianthus Therapeutics's debt-to-assets decreased by 72.5% year-over-year, from 0× to 0×.
What is the long-term trend for Dianthus Therapeutics's debt-to-assets?: Over 3 years (2022 to 2025), Dianthus Therapeutics's debt-to-assets has grown at a -80.7% compound annual growth rate (CAGR), from 0.4× to 0×.
What does debt-to-assets mean?: Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.